February 10, 2013 - Volume 35 - Issue - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Author Name Article
Susman, Ed

A New Take on ‘Chemo Brain’

Free Access
PDF
+ Favorites
Request Permissions
Sledge, George W. Jr., MD

MUSINGS OF A CANCER DOCTOR: Taking Off from San Antonio

Free Access
PDF
+ Favorites
Request Permissions
Rosenthal, Eric T.

How the Evolving Link Between Science and Advocacy at SABCS has Grown Even Stronger

Free Access
PDF
+ Favorites
Request Permissions
O'regan, Ruth MD

Key Takeaways about Hormonal Therapy for Metastatic Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions
Morikawa, Aki MD, PhD

Key Takeaways about Metastatic Triple-Negative Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions
Ma, Cynthia X. MD, PhD

Key Takeaways about Breast Cancer Biology: Better Therapy Promised for Triple-Negative Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions
Laino, Charlene

Neoadjuvant Chemotherapy Shown to Benefit Many Younger Women with Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions
Gradishar, William MD

Key Takeaways Related to HER2 Therapy

Free Access
PDF
+ Favorites
Request Permissions
DiGiulio, Sarah

Black Patients Less Likely to Receive Sentinel Lymph Node Biopsy, Increasing Lymphedema Risk

Free Access
PDF
+ Favorites
Request Permissions
Carlson, Robert H.

ATLAS Trial: ‘Carryover’ Effect of Tamoxifen Extends to 15 Years

Free Access
PDF
+ Favorites
Request Permissions

Postmenopausal Patients: Letrozole Benefit Varies by Histology and ER-Subtype

Free Access
PDF
+ Favorites
Request Permissions

Kathy Albain on the Significance of ATLAS & BIG for Early/Late Tamoxifen

Free Access
PDF
+ Favorites
Request Permissions

BOLERO-2 Study: Everolimus-Exemestane Overcomes Al Resistance

Free Access
PDF
+ Favorites
Request Permissions

Vitamin D Levels Predict Relapse in Early Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions

Metformin Excitement Slows

Free Access
PDF
+ Favorites
Request Permissions

CONFIRM Trial: Confirmation of Clinical Experience that Higher-Dose Fulvestrant is Better than Lower Doses in Advanced ER+ Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions

Metastatic Breast Cancer: PD 0332991 + Letrozole Triples PFS

Free Access
PDF
+ Favorites
Request Permissions

Routine MRI Use Not Recommended in Managing Breast Cancer

Free Access
PDF
+ Favorites
Request Permissions